ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer
| Autor: | Barok, Mark, Le Joncour, Vadim, Martins, Ana, Isola, Jorma, Salmikangas, Marko, Laakkonen, Pirjo, Joensuu, Heikki |
|---|---|
| Zdroj: | In Cancer Letters 31 March 2020 473:156-163 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect